Long-acting disease-modifying therapies do not appear to increase the risk of complications following autologous hematopoietic stem cell transplantation (aHSCT), according to a retrospective study from Sweden (Kvistad et al. J Neurol Neurosurg Psychiatry 2022;93:844-848). Read More
Latest News
COVID-19 and MS – updated findings
July 28, 2022The following is a summary of recent findings on COVID-related issues in patients with multiple sclerosis. Read More
COVID update: the 7th wave
July 13, 2022Ontario and Quebec have announced that they are now seeing a seventh wave of COVID-19 infections, although case numbers are uncertain due to a lack of reporting. Health Canada reports 21,317 new cases for the week ending July 8, but acknowledges that this is an underestimate (https://health-infobase.canada.ca/src/data/covidLive/Epidemiological-summary-of-COVID-19-cases-in-Canada-Canada.ca.pdf). The Northwest Territories and Nunavut no longer publish COVID case numbers while Saskatchewan posts case numbers only once a month. Read More